Title:Zolpidem Arousing Effect in Persistent Vegetative State Patients: Autonomic, EEG and Behavioral Assessment
Volume: 20
Issue: 26
Author(s): Calixto Machado, Mario Estevez, Rafael Rodriguez, Jesus Perez-Nellar, Mauricio Chinchilla, Philip DeFina, Gerry Leisman, Frederick R. Carrick, Robert Melillo, Adam Schiavi, Joel Gutierrez, Maylen Carballo, Andres Machado, Ana Olivares and Nuvia Perez-Cruz
Affiliation:
Keywords:
Persistent vegetative state, Zolpidem, heart rate variability, autonomic, EEG, arousal.
Abstract: Objective. To study the Zolpidem arousing effect in persistent vegetative state (PVS) patients combining clinical evaluation,
autonomic assessment by heart rate variability (HRV), and EEG records. Methods. We studied a group of 8 PVS patients and other 8
healthy control subjects, matched by age and gender. The patients and controls received drug or placebo in two experimental sessions,
separated by 10-14 days. The first 30 minutes of the session were considered the basal record, and then Zolpidem was administered. All
participants were evaluated clinically, by EEG, and by HRV during the basal record, and for 90 minutes after drug intake. Results. We
found in all patients, time-related arousing signs after Zolpidem intake: behavioral (yawns and hiccups), activation of EEG cortical activity,
and a vagolytic chronotropic effect without a significant increment of the vasomotor sympathetic tone. Conclusions. We demonstrated
time-related arousing signs after Zolpidem intake. We discussed possible mechanisms to explain these patho-physiological findings
regarding EEG cortical activation and an autonomic vagolytic drug effect. As this autonomic imbalance might induce cardiocirculatory
complications, which we didn’t find in any of our patients, we suggest developing future trials under control of physiological
indices by bedside monitoring. However, considering that this arousing Zolpidem effect might be certainly related to brain function improvement,
it should be particularly considered for the development of new neuro-rehabilitation programs in PVS cases. According to the
literature review, we claim that this is the first report about the vagolitic effect of Zolpidem in PVS cases.